ACI
BIO icon

AMP Capital Investors’s Bio-Rad Laboratories Class A BIO Stock Holding History

AMP Capital Investors’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-11,024
Closed -$8.22M – 296
2021
Q3 		$8.22M Sell
11,024
-2,779
-20% -$2.08M 0.05% 422
2021
Q2 		$8.89M Buy
13,803
+540
+4% +$329K 0.04% 440
2021
Q1 		$7.57M Sell
13,263
-5,211
-28% -$3.09M 0.04% 484
2020
Q4 		$10.6M Buy
18,474
+1,740
+10% +$991K 0.06% 359
2020
Q3 		$8.62M Sell
16,734
-5,373
-24% -$2.72M 0.05% 390
2020
Q2 		$9.55M Buy
22,107
+1,480
+7% +$653K 0.06% 333
2020
Q1 		$7.2M Buy
20,627
+7,634
+59% +$2.81M 0.05% 359
2019
Q4 		$4.8M Sell
12,993
-680
-5% -$240K 0.03% 571
2019
Q3 		$4.57M Sell
13,673
-1,250
-8% -$408K 0.03% 564
2019
Q2 		$4.58M Sell
14,923
-1,297
-8% -$388K 0.03% 544
2019
Q1 		$4.93M Sell
16,220
-3,829
-19% -$1.03M 0.03% 539
2018
Q4 		$4.6M Sell
20,049
-601
-3% -$161K 0.03% 518
2018
Q3 		$6.45M Sell
20,650
-670
-3% -$208K 0.04% 490
2018
Q2 		$6.15M Sell
21,320
-140
-0.7% -$38.7K 0.03% 496
2018
Q1 		$5.31M Buy
21,460
+2,970
+16% +$756K 0.03% 524
2017
Q4 		$4.41M Buy
18,490
+1,210
+7% +$293K 0.02% 565
2017
Q3 		$3.84M Buy
17,280
+15,540
+893% +$3.5M 0.02% 597
2017
Q2 		$390K Sell
1,740
-90
-5% -$19.6K ﹤0.01% 1013
2017
Q1 		$365K Buy
1,830
+670
+58% +$129K ﹤0.01% 1028
2016
Q4 		$213K Buy
+1,160
New +$198K ﹤0.01% 1131

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $60.9B AUM 15.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

AMP Capital Investors's BIO Position: Q4 2021 in Review

AMP Capital Investors sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2021, closing a stake of 11,024 shares — an estimated $8.22M sold.

AMP Capital Investors first reported a position in BIO in Q4 2016 and held it in 20 quarters. The position peaked at $10.6M in Q4 2020. 534 funds tracked by Wall St. Rank hold BIO as of Q4 2021.

  • AMP Capital Investors reported no remaining Bio-Rad Laboratories Class A position as of Q4 2021 after selling out during the quarter.
  • AMP Capital Investors sold 11,024 Bio-Rad Laboratories Class A shares in Q4 2021, an estimated $8.22M.
  • AMP Capital Investors first reported a position in Bio-Rad Laboratories Class A in Q4 2016 and held it in 20 quarters.
  • AMP Capital Investors's Bio-Rad Laboratories Class A position peaked at $10.6M in Q4 2020.
  • 534 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2021.

Based on AMP Capital Investors's 13F filing for Q4 2021, filed 14 Feb 2022.